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Abstract [max 300 wd; complete sentences required; now 312 wd] 43 
Background: Bed rest studies document a lower dietary acid load is associated with lower bone 44 
resorption.  45 
Objective: We tested the effect of dietary acid load on bone metabolism during spaceflight.  46 
Design: Controlled 4-d diets with a High or Low ratio of animal protein to potassium (APro:K) 47 
were given to 17 astronauts before and during spaceflight. Each astronaut had 1 High and 1 Low 48 
diet session before flight and 2 High and 2 Low sessions during flight. In a fifth 4-d session 49 
around flight day 30 (FD30), crewmembers were to consume their typical in-flight intake. At the 50 
end of each session, blood and urine samples were collected. Calcium, total protein, energy, and 51 
sodium were maintained in each crewmember’s preflight and in-flight controlled diets.  52 
Results: N-telopeptide (NTX) and urinary calcium were higher during flight. Bone-specific 53 
alkaline phosphatase (BSAP) was higher toward the end of flight. The High and Low diets did 54 
not have an effect on NTX, BSAP, or urine calcium. Dietary sulfur and age were significantly 55 
associated with changes in NTX. Dietary sodium and flight day were significantly associated 56 
with urinary calcium during flight. The net endogenous acid production (NEAP) estimated from 57 
the typical dietary intake at FD30 was associated with loss of bone mineral content in the lumbar 58 
spine after the mission. Resistive exercise during flight is likely a confounding factor. The results 59 
were compared to data from a 70-d bed rest study, in which control (but not exercising) subjects’ 60 
APro:K was associated with higher NTX during bed rest.  61 
Conclusions: Long-term lowering of NEAP by increasing vegetable and fruit intake may protect 62 
against changes in loss of bone mineral content during spaceflight when adequate calcium is 63 
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consumed, particularly if resistive exercise is not being performed, but further investigation is 64 
needed.  65 
 66 
Keywords: animal protein, bone mineral content, bone resorption, bone-specific alkaline 67 
phosphatase, dietary acid, dietary sulfur, N-telopeptide, net endogenous acid production, 68 
resistive exercise, weightlessness  69 
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Introduction 70 
Though the mechanism of bone mineral loss associated with spaceflight is not completely 71 
understood, it is clearly multifactorial. With adequate nutritional support, resistive exercise can 72 
mitigate decrements in bone mineral density (BMD) during spaceflight (1, 2), and it is likely that 73 
diet can be optimized to further protect bone (3, 4). While pharmacological agents provide an 74 
alternative in the event of exercise device failure (5), avoiding these agents in otherwise healthy, 75 
relatively young individuals seems prudent. Dietary effects on bone are well established, and 76 
have virtually no risk of side effects. 77 
Ground-based evidence supports the hypothesis that a suboptimal diet is associated with 78 
lower bone mineral status and higher osteoporosis and fracture risk in healthy subjects (6). 79 
Mediterranean diets rich in fruits and vegetables are generally beneficial to bone (7-9), possibly 80 
because low endogenous acid production is associated with fruit and vegetable intake. 81 
Endogenous acids include sulfuric acid produced from sulfur-containing proteins and amino 82 
acids. Generally, foods containing animal protein are higher in sulfur-containing amino acids 83 
than plant protein sources, and plants have a higher content of alkaline precursors. Phosphoric 84 
acid is another nonvolatile acid that can either be ingested in the diet or produced endogenously. 85 
Anions, including conjugate bases of organic acids, make up the majority of dietary base 86 
precursors that the body metabolizes to bicarbonate. Potassium is the predominant intracellular 87 
inorganic cation that balances the charge of organic anions; therefore, dietary potassium intake 88 
can be used to estimate the content of base precursors in the diet. Frassetto and colleagues 89 
developed a model for estimating net endogenous acid production (NEAP) on the basis of the 90 
acid and base precursors in the diet (10). According to this model, renal net acid excretion can be 91 
predicted from 2 dietary components: total protein and potassium. 92 
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In bed rest, a common analog of spaceflight effects on bone, we showed that a higher 93 
ratio of dietary animal protein to potassium (Apro:K) was associated with more excretion of both 94 
calcium and collagen crosslinks, but had no association with markers of bone formation (11, 12). 95 
While this observation was clear after 2-3 wk of bed rest, it was not as profound before bed rest 96 
when the subjects were ambulatory. This suggests that the impact of diet on bone is more 97 
pronounced in non-exercising individuals, specifically those whose bone is in a resorptive state, 98 
as is the case during bed rest. In a separate study in which bed rest subjects were supplemented 99 
with essential amino acids including methionine (a sulfur-containing amino acid), urine pH was 100 
lower and markers of bone resorption were higher in subjects receiving the supplement, while 101 
bone formation was not affected (13).   102 
On the basis of these findings, we proposed that the ratio APro:K in the diet would be 103 
associated with bone metabolism during spaceflight. We report here results from a controlled 104 
diet study in which we investigated acute effects of controlled diets on biochemical markers of 105 
bone metabolism. For comparison, similar data from a 70-d ground-based bed rest study 106 
evaluating exercise effects on bone and other systems are also presented. 107 
 108 
Subjects and Methods 109 
Seventeen International Space Station (ISS) astronauts (13 male and 4 female, 47 ± 6 y at 110 
the time of launch, BMI 24.6 ± 3.0; mission durations of 160 ± 20 d, mean ± SD) participated in 111 
the study. The protocol was reviewed and approved by the National Aeronautics and Space 112 
Administration (NASA) Johnson Space Center (JSC) Institutional Review Board, the Japanese 113 
Aerospace Exploration Agency, and the European Space Agency Medical Boards. Written 114 
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informed consent was obtained from all crewmembers before their participation. While we have 115 
published other bone and related data from astronauts on ISS missions, none of the data reported 116 
here have been previously published, and none of the data from the astronauts included here 117 
were included in those other publications. 118 
 119 
Dietary treatments, recording, and analysis 120 
The experimental goal was to test 2 diets: one (“High”) with a “high” ratio of animal 121 
protein:potassium (1.0-1.3 g animal protein/mEq potassium), and one (“Low”) with a “low” ratio 122 
(0.3-0.6 g/mEq). The ranges were selected to represent the high end and low end of the linear 123 
relationship between dietary APro:K and NTX from a bed rest study (11). Four-day menus for 124 
each diet were developed from available space foods, and foods for each crewmember were 125 
developed from the same lot for both the preflight and in-flight controlled-diet sessions. The 126 
High and Low 4-d menus for each crewmember were designed to provide similar (within 5% of 127 
each other) intakes of total energy (based on WHO calculations for that crewmember (14)), total 128 
protein, sodium, and calcium intakes within a crewmember. A research dietitian met with each 129 
crewmember in advance to plan acceptable High and Low menus given the available space 130 
foods. Identical menus were provided in a semi-randomized crossover fashion, such that each 131 
crewmember had 1 High and 1 Low diet session before flight and 2 High and 2 Low sessions 132 
during flight. The randomization was stunted to yield (roughly) equal numbers of High and Low 133 
diet sessions at each of the designated time points during flight. The preflight sessions occurred 134 
at about 6 mo and at 3 mo before the mission, and the in-flight sessions occurred around flight 135 
day (FD) 15, FD60, FD120, and FD180. All crewmembers completed at least 3 controlled diet 136 
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sessions, but not all crewmembers completed all 4 controlled diet intake sessions during flight 137 
due to the shorter durations of some missions. Note that, although 7, 8, or 9 subjects participated 138 
in each of the High or Low sessions, because of randomization participants were not the same 139 
individuals from one session to the next. 140 
In addition to the controlled dietary intake sessions during flight, there was a 4-d session 141 
at FD30 when crewmembers had no dietary restrictions but during those 4 d were asked to 142 
consume and record their typical intake. This session was intended to provide an understanding 143 
of the crewmembers’ typical intake during the mission. Crewmembers completed similar 4-d 144 
monitored intake sessions after flight (return plus (R+) 30, 180, 365) (data not reported here). A 145 
fasting blood sample and a 24-h urine collection were also obtained about 10-45 d before flight 146 
with no diet monitoring (and no diet restrictions).   147 
Dietary intake data were collected and analyzed using Nutrition Data System for 148 
Research software versions 2007, 2010, 2012, and 2014 developed by the Nutrition Coordinating 149 
Center (NCC), University of Minnesota, Minneapolis, MN. Space foods are analyzed in the 150 
Water & Food Analytical Laboratory (WAFAL) at NASA JSC for macronutrient and mineral 151 
content including moisture, fat (total, saturated, and unsaturated), fiber, protein, carbohydrate, 152 
calories, calcium, magnesium, sodium, potassium, phosphorus, copper, iron, manganese, zinc, 153 
chloride, iodine, fatty acid profile, and cholesterol. Recipes and nutrients analyzed by the 154 
WAFAL lab for each food item were submitted to the NCC and the content of other nutrients 155 
was imputed according to the analyzed data and recipes. Dietary sulfate was determined using an 156 
equation from Remer and colleagues (15). Diets were designed for each individual crewmember 157 
according to their estimated energy requirements (14) and study constraints. In some cases, 158 
however, a crewmember simply could not consume the prescribed amount of food, and in other 159 
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cases crewmembers reported being hungry at the end of the day when the allotted food items 160 
were depleted. In the former cases, attempts were made to adjust menus for subsequent sessions 161 
to maintain study constraints at lower energy intakes. In the latter cases, non-protein-containing 162 
food items were provided to increase calories. Actual intakes are reported in the results. 163 
All crewmembers were provided with vitamin D supplements (800 IU/d) during flight. 164 
They were asked to refrain from taking any other supplements during the 4-d controlled dietary 165 
intake sessions.  166 
NEAP was calculated from dietary components using an equation from Remer and Manz  167 
(15), which incorporates the potential renal acid load of the diet and the diet-independent organic 168 
acid excretion estimated from body surface area.  169 
Biological Sample Collections and Biochemical Analyses 170 
At the end of each 4-d session, 24-h urine samples and fasting blood samples were 171 
collected, with the closing urine void collected at around the same time as the fasting blood 172 
draw. We have previously reported the details of techniques and equipment used for in-flight 173 
biological sample collections and processing (1, 16).  174 
Blood samples were analyzed for bone biochemical markers using standard techniques, 175 
as described previously (1, 2). Urine samples were analyzed for collagen crosslinks, including 176 
NTX, C-telopeptide, and helical peptide (HP), using commercially available kits (Osteomark, 177 
Ostex International, Seattle, WA; Osteometer BioTech, Herley, Denmark; and Quidel, San 178 
Diego, CA, respectively). Urinary sulfate was measured as previously described (17). Urinary 179 
pH was measured in 24-h urine collections using a standard pH meter. Urine pH was determined 180 
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during flight using a paper strip technique, but we found that the lighting on board the ISS 181 
coupled with the color gradations on the strip did not allow clear resolution of pH. 182 
   183 
Exercise 184 
All crewmembers regularly performed resistive exercise on the ISS Advanced Resistive 185 
Exercise Device (ARED) (2, 18). The types of exercise performed on the ARED include squats, 186 
heel raises, deadlift, shoulder press, abdominals, and bent-over row. All exercises performed on 187 
the ARED were included in the reported totals. The amount of exercise was determined by 188 
multiplying the amount of weight used by the number of repetitions and sets for each exercise 189 
performed on the device. The daily total pounds lifted in the 3 wk before the blood and urine 190 
collection associated with each dietary session was then calculated. If less than 3 wk of data were 191 
available (i.e., for the FD15 session), then only the available data were used.   192 
 193 
Bone Densitometry 194 
BMC and BMD were assessed about 3 mo before and within 1 mo after each flight by 195 
dual-energy x-ray absorptiometry (DXA) with a fan beam densitometer (Hologic Discovery; 196 
Hologic, Inc., Waltham, MA, USA) as described previously (2). 197 
 198 
Environmental Data 199 
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ISS cabin carbon dioxide (CO2) was determined by the ISS Cabin Gas Analyzer and by 200 
the Major Constituent Analyzer. The average of the 2 measurements in the 24-h day of each 201 
blood draw was used in the analyses. 202 
 203 
Bed Rest 204 
Comparison data are reported here from a bed rest study evaluating exercise as a 205 
countermeasure to physiological effects of simulated microgravity (19). These data are from one 206 
of a series of bed rest studies conducted at the University of Texas Medical Branch (UTMB) in 207 
Galveston, TX (20). Protocols were reviewed by the NASA JSC and UTMB institutional review 208 
boards, and written informed consent was obtained before participation. 209 
While we and others have reported data from this (19) and similar (21, 22) bed rest 210 
studies, to our knowledge, none of the data reported here have been published previously (and 211 
certainly no data pertaining to dietary APro:K effects on bone).  212 
Subjects (n=11, 10 M, 1 F; ages 38 ± 7; BMI 25.2 ± 2.2) participated in a 70-d 6° head-213 
down-tilt bed rest study. Five subjects completed daily supine exercise, which started on the first 214 
day of bed rest, and 6 subjects served as non-exercising controls. The exercise consisted of 215 
aerobic and resistance exercise (eg, squat, heel raise, leg press, cycling, and treadmill), designed 216 
to be similar to the exercise profiles being tested on the ISS.   217 
Subjects were housed in the Institute for Translational Sciences-Clinical Research Center 218 
(ITS-CRC) at UTMB (Galveston, TX) for at least 13 d before the start of bed rest until 6 d after 219 
reambulation following the 70-d bed rest phase of the study. Food was weighed and dietary 220 
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intake was recorded daily by metabolic kitchen staff, as described for similar bed rest studies in 221 
the ITS-CRC (23). These diets were controlled, but not with respect to the APro:K ratio. For this 222 
report, the dietary intake data were analyzed for the 7 d before the urine collection and an 223 
average APro:K was determined. Urine was collected in 24-h pools 4 times before bed rest 224 
(collected 10, 9, 3, and 2 d before bed rest) and monthly during bed rest. For this report, the pre-225 
bed rest NTX average represents the average NTX of the 4 days before bed rest, and the bed rest 226 
NTX is the average of the last 2 days of bed rest (bed rest days 69 and 70).  227 
 228 
Statistical Analyses 229 
To test for differences in demographic, in-flight exercise, environmental, and reported 230 
dietary intake measures between astronauts assigned to High and Low APro:K diets at FD15, 231 
FD60, FD120, and FD180, we used 2-sided t-tests and Fisher’s exact tests for continuous and 232 
discrete data, respectively. Additionally, we used 2-sided, paired t-tests to investigate differences 233 
between astronauts’ mean in-flight exercise, environmental, and dietary intake measures while 234 
they were on the monitored diet session at FD30 and the same measures while they were on High 235 
or Low APro:K diets at FD15, FD60, FD120, and FD180. To control the familywise error rate, 236 
we adjusted the ߙ-level of the tests using a false discovery rate adjustment (24): we restricted the 237 
false discovery rate to 0.05, which means that we would expect 5% of the rejected null 238 
hypotheses to be false (incorrect rejection).  239 
Two mixed-effects linear regression models were fit using the lme4 package (25) in R 240 
(26) to assess differences in the changes in urinary NTX, BSAP, and daily urinary calcium 241 
excretion from baseline across assigned diets (High APro:K, Low APro:K, monitored) for 242 
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measures collected before and during flight (first model), and for in-flight measures only (second 243 
model). All dependent variables (urinary NTX, BSAP, urinary calcium) were normalized by 244 
subtracting astronauts’ respective baseline measures collected 10 d before flight, when they were 245 
not on a controlled (or monitored) diet. We incorporated a random intercept term in each model, 246 
which accommodated random heterogeneity in astronauts’ changes in NTX, BSAP, and urinary 247 
calcium from baseline that persisted throughout the study. Diet was treated as a 3-level 248 
categorical covariate and modeled using indicator variables, with the monitored diet session 249 
serving as the reference category. Each model controlled for fixed effects of age, body mass (kg), 250 
sex (male as reference), energy (kcal/d), total protein (g), dietary sulfur (mEq/d), dietary 251 
potassium (mg), dietary calcium (mg), dietary sodium (mg), NEAP, and flight day. For the first 252 
(preflight and in-flight) model, we incorporated a main effect for in-flight status (using preflight 253 
data as reference) and an interaction between in-flight status and relative day from launch when 254 
significant. For the in-flight-only models, we additionally controlled for cumulative 3 wk of 255 
exercise (lbs) and average CO2 (mmHg). P values for significance of the regression coefficient 256 
were obtained using the Kenward-Roger approximation with R package pbkrtest (27). 257 
Significance was determined at the 0.05 α-level. 258 
FD30/DXA analysis 259 
We assessed whether changes in BMC and BMD after spaceflight were associated with 260 
dietary protein using simple linear regression models. Thereafter, we fit multiple regression 261 
models to investigate whether dietary sulfur confounded these relationships. Additionally, we 262 
took a similar approach to assess whether changes in total lumbar spine BMC were associated 263 
with NEAP at FD30, controlling for age and sex. Significance was determined at the 0.05 α-264 
level. 265 
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 266 
Bed Rest Analyses 267 
Pearson correlation coefficients were determined for the control and exercise groups for 268 
the 7-d mean APro:K (7 d before urine collections) and the average pre-bed rest NTX as well as 269 
the average NTX from bed rest days 69 and 70.  270 
 271 
Results 272 
All crewmembers completed all planned sessions, although 3 had truncated mission 273 
durations and as a result could not complete an FD180 session. Demographic, in-flight exercise 274 
and CO2, and summary dietary intake data are shown in Table 1. An extended set of intake data 275 
are provided in Supplemental Table 1. It is important to recall that crewmembers did not follow 276 
the same pattern of diets, and thus the subjects in the High or Low groups were not the same 277 
individuals from one session to the next. This was accounted for in the analysis. 278 
Energy intake was generally maintained during High and Low APro:K diet sessions, but 279 
small adjustments were made when crewmembers felt they could not consume the food that met 280 
estimated energy requirements or when crewmembers requested additional food because they 281 
were hungry. Energy intake during the controlled sessions was higher than in the FD30 282 
monitored intake session (Table 1). As designed, dietary total protein, calcium, and sodium were 283 
maintained during crewmembers’ controlled dietary intake sessions. NEAP was different 284 
between the 2 diets, significantly higher with High than with Low menus, as expected (Table 1).  285 
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ISS cabin CO2 concentration was generally constant between sessions (Table 1). With an 286 
average close to 3 mm Hg on the ISS, CO2 concentration was much higher than terrestrial CO2 at 287 
standard pressure (0.3 mm Hg). 288 
We evaluated 3 key bone markers: urinary NTX and calcium, and serum BSAP. 289 
Summaries of the measures collected are presented in Figure 1 and Table 2, and the results of 290 
the linear mixed-effects model for preflight and in-flight measures as well as the model with only 291 
in-flight measures are shown in Tables 3-5.  292 
As expected, NTX increased during flight (raw and change data are presented in Table2, 293 
statistical models are presented in Table 3). In the preflight and in-flight model (Table 3), the 294 
High (P = 0.06) and Low (P = 0.39) diets were not significantly associated with changes in NTX 295 
compared to the monitored diet on FD30. However, age (P < 0.01) and dietary sulfur (P = 0.03) 296 
were significantly associated with changes in NTX from baseline. Specifically, in looking at the 297 
estimate numbers in Table 3, for every 10 mEq/d increase in dietary sulfur and year increase in 298 
age, we would expect an 80 and 18 nmol/d increase in excretion of NTX, respectively, for the 299 
typical astronaut, holding all else constant. When we investigated the potential confounding 300 
effects of exercise and CO2 exposure (looking at in-flight data only), the High Apro:K diet was 301 
associated with a decrease in NTX. However, further investigation revealed that this relationship 302 
was potentially driven by 1 individual who had a sharp increase in NTX from baseline when not 303 
on a controlled diet at FD30 (see Supplemental Figure 1). Refitting the model with the 304 
individual removed negated the significant difference (P = 0.130, Table 3). For the in-flight-only 305 
model, only age remained significantly associated with changes in NTX from baseline (P = 0.02, 306 
Table 3). However, the magnitudes of the effects were relatively consistent between the preflight 307 
and in-flight model and the in-flight only model. The same model was applied to urinary CTX 308 
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and helical peptide, 2 additional markers of bone resorption, and the results were generally 309 
similar to what was observed for NTX (data not shown). 310 
The data did not provide enough evidence to suggest that either the High or the Low 311 
APro:K controlled diet was significantly associated with differences between serum BSAP 312 
during flight and serum BSAP during the FD30 monitored session, in either model (Table 4). 313 
BSAP increased during flight (Table 2), and increased further with increased duration of flight 314 
(P < 0.0001 for flight day in the pre- and in-flight model). For the in-flight only model, flight day 315 
remained significant (P < 0.001) and CO2 also had a small but significant (P = 0.01) association 316 
with BSAP (Table 4). For every 10-d increase in days of flight, we would expect a 1-U/L 317 
increase in BSAP for the typical astronaut, holding all else constant. Also, for every 1-mmHg 318 
increase in average CO2 during flight, we would expect a 3-U/L increase in BSAP for the typical 319 
astronaut, holding all else constant. 320 
The urinary calcium data also did not provide enough evidence to suggest that either the 321 
High or the Low APro:K controlled diet was significantly associated with differences between 322 
urinary calcium excretion during flight and urinary calcium during the FD30 monitored session 323 
(Table 5); however, higher dietary sodium was associated with higher urinary calcium (P < 0.05) 324 
in both of the mixed-effects models. Urinary calcium was significantly higher during flight than 325 
before flight (P < 0.0001), but there was a significant interaction between flight day and in-flight 326 
status (P < 0.0001). Thus, as time in flight (flight day) increased, urinary calcium increased at a 327 
slower rate (change and percentage change decreased). When looking at the in-flight only model, 328 
which controlled for CO2 and exercise, there was still no statistically significant difference 329 
between the High or the Low Apro:K diet and a monitored diet, for urinary calcium. Dietary 330 
sodium and flight day remained significant during flight. 331 
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Dietary intake from the FD30 monitored session, used as a representation for typical in-332 
flight dietary intake, revealed that a higher acid load (estimated by NEAP) was associated with a 333 
greater decrease in BMC of the lumbar spine (Figure 2, P < 0.01).  334 
 In the bed rest study, APro:K was not correlated with urinary NTX before bed rest, but 335 
was correlated with NTX in the control (no exercise) subjects during bed rest (r = 0.82, P < 0.05) 336 
(Figure 3). This effect was not observed in exercising subjects, and during bed rest those 337 
subjects showed a trend for a negative correlation (r = -0.84, P = 0.07). The bed rest dietary 338 
intake data are presented in Supplemental Table 2. 339 
 340 
Discussion 341 
The literature on the effects of protein (type and amount) on bone are mixed, with some 342 
studies demonstrating that diets providing a high protein intake are detrimental to bone (28, 29); 343 
conversely, many studies report high protein intake having a protective effect on bone (30, 31). 344 
In light of our previous bed rest data showing that the ratio of dietary APro:K was positively 345 
associated with urinary NTX excretion (11), we hypothesized that a higher APro:K diet during 346 
spaceflight would yield a greater change in urinary NTX excretion than a diet with lower 347 
APro:K, and we hypothesized that diet would have no effect before flight. Contrary to our 348 
hypothesis, we did not observe any differences in the effect on bone turnover markers when 349 
crewmembers were on a High or a Low APro:K ratio controlled diet for 4-d periods during 350 
flight. Rather than concluding that our findings support the argument that there is no effect, or a 351 
positive effect, of protein on bone, we rather maintain that these results help to clarify the discord 352 
in the literature.   353 
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 The majority of the studies reporting detrimental effects of protein on bone had less than 354 
optimal calcium intake, and the studies reporting beneficial effects on bone had calcium intakes 355 
adequate to support bone formation (32-34). Jonge and colleagues (35) found that dietary acid 356 
load may be associated with negative bone outcomes only in subgroups of individuals. They 357 
found that in individuals with higher intakes of dietary fiber, a higher NEAP was more 358 
detrimental to bone; this result was hypothesized to be caused by inhibited intestinal absorption 359 
of calcium (35). In our study, dietary fiber was twice as high in the Low menus as in the High 360 
menus. We included dietary fiber in the statistical models, but it was not significant for any of 361 
the outcomes studied. It is also important to point out that crewmembers in this flight study were 362 
consuming high-protein diets overall, relative to the current RDA of 0.8 g protein/kg. The 363 
average protein intake during the controlled diet sessions was 1.5 ± 0.2 g/kg body weight (BW) 364 
(1.2 ± 0.4 g/kg BW for the FD30 session). Also, average calcium intake was 1275 ± 229 mg/d 365 
(1118 ± 397 mg/d during the FD30 session), which is more than sufficient to support bone 366 
formation. High protein intake is often argued to be detrimental to bone because it is often 367 
associated with increased urinary calcium excretion. For every 10-g increase in dietary protein, 368 
urinary calcium increases by 16 mg (36), and because excess dietary protein is catabolized to 369 
ammonium ion and sulfates from the sulfur-containing amino acids, it has been hypothesized that 370 
bone is resorbed to neutralize the dietary acid load. A key consideration is that increased dietary 371 
protein increases calcium absorption in some studies (37-39). In our study, when comparing 372 
dietary effects on NTX before and during flight, we found that a higher dietary sulfur intake was 373 
associated with an increase in urinary NTX excretion, but it was not associated with urinary 374 
calcium. Dietary sodium had a small but significant positive association with urinary calcium. 375 
Higher dietary sodium was not associated with a greater change in NTX, though, so it is possible 376 
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that the calcium could come from increased intestinal absorption instead of being released from 377 
bone. We previously documented that calcium absorption decreased during spaceflight, but that 378 
was in crewmembers who did not have access to resistance exercise (40, 41). Interestingly, 379 
Thorpe and colleagues found a positive association of lumbar spine BMD with dietary protein in 380 
postmenopausal women consuming adequate calories, but the association was suppressed by a 381 
negative association with protein sulfur. Sulfur intakes were around 30 mEq/d in that study, 382 
which was about half of the sulfur intake of the crewmembers in this study. We attempted to 383 
reproduce these findings with the monitored intake data at FD30, but the total protein and sulfur 384 
were highly correlated (Pearson’s r = 0.9968), and therefore we could not effectively tease out 385 
effects of sulfur and protein. 386 
Exercise, or even degree of ambulation, is a major factor in these studies. Exercise is an 387 
operational countermeasure on the ISS, meaning that all crewmembers on the ISS are required to 388 
exercise – using both aerobic and resistive exercise devices before and throughout their missions 389 
(42, 43). In this study, all crewmembers had access to heavy resistance exercise, which has been 390 
shown to mitigate bone loss during flight (2, 41) and in bed rest (44). Our previous bed rest 391 
studies showed the positive relationship between APro:K and NTX, and this relationship was 392 
more pronounced in control subjects than in exercising subjects (11), and more pronounced in 393 
men (11) than women (12). The exercise in those studies was a unique protocol combining 394 
aerobic (treadmill) exercise with lower-body negative pressure. In the bed rest study reported 395 
here, diet had no effect on bone resorption during the ambulatory pre-bed rest phase. During bed 396 
rest, there was a significant association of diet and bone resorption in sedentary subjects, which 397 
was absent in exercising subjects. 398 
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 Because the High and Low diets were only 4 d and not representative of the entire 399 
mission intake, we could not look at those diets with respect to overall changes in BMC. The 400 
FD30 monitored dietary intake session is the closest estimate we have to give a snapshot of the 401 
typical intake of the crewmembers during the other ~160 d of the mission when their diets were 402 
not controlled for this study. For the 4 d of that monitored session, crewmembers were asked to 403 
record all fluid and food intake with no restrictions on what they could have. The NEAP average 404 
from FD30, estimated from acid and base components of the diet, was negatively associated with 405 
the change in lumbar spine BMC. We specifically looked at lumbar spine BMC because in 406 
previous studies it was the region with the highest percentage change from preflight values for 407 
crewmembers using the ARED (2). Total BMD and BMC were not related to NEAP, and it is 408 
possible that diet effects on these whole-body measurements are swamped by the protective 409 
effect of exercise. Furthermore, Remer and colleagues (45) have suggested that the potential 410 
renal acid load of the diet may be more related to the cortical area of the bone (bone size) as 411 
assessed by peripheral quantitative computed tomography (pQCT), and not to areal BMD as is 412 
assessed by DXA. This hypothesis is based on previous pQCT findings that dietary potential 413 
renal acid load was associated with cortical area and BMC but not with volumetric cortical BMD 414 
(46). Remer et al. argue that true volumetric density, bone thickness, and bone size are integrated 415 
into a single number with DXA, and the acid load of the diet may be more closely related to bone 416 
size and bone mass than to the BMD measurement (45). We unfortunately don’t have pQCT data 417 
for the crewmembers in this study, but the relationship between dietary acid load and impact on 418 
bone is worthy of future testing.  419 
A potential limitation/confounding factor of the present study could be that the 4-d 420 
controlled dietary sessions were simply not long enough to observe an effect on bone turnover 421 
22 
 
markers. Studies have documented rapid (ie, within days) increases in bone resorption response 422 
to bed rest (47) and response to dietary changes during bed rest (48, 49), but response to dietary 423 
changes with 4-d menus has not been evaluated during spaceflight. In light of the observation 424 
that FD30 NEAP was associated with BMC loss, and assuming that intake during the FD30 425 
session accurately represented the typical intake for the entire mission, it is possible that we 426 
simply missed this relationship with the biochemical markers after 4 d of controlled diets, and 427 
that 4 d was not long enough to observe the effect on bone biochemistry, or even that the NEAP 428 
of the diet should have been the driving factor behind the High and Low diets instead of Apro:K. 429 
Now that detailed, daily dietary intake logging has been initiated on the ISS (as opposed to 430 
weekly questionnaires), more detailed analyses regarding the effect of overall mission dietary 431 
intake on bone and other systems will be possible. 432 
An abundance of literature exists on both sides of the protein/bone question. We have 433 
long maintained that spaceflight and flight analog research highlights the fact that neither side is 434 
“right,” and that the effect of protein on bone depends on many factors – key among them being 435 
adequacy of other dietary components (calcium, energy, etc) and ambulation (50, 51). While we 436 
had hoped this study would yield a dietary countermeasure for spaceflight-induced bone loss, 437 
and expected the microgravity environment to offer a better model of bone loss than bed rest, it 438 
seems the effects of exercise in protecting BMD during flight (2) swamp the dietary effects on 439 
bone. While this result further documents the complexity of this relationship, it does not dismiss 440 
our basic tenet that providing a long-term diet rich in fruits and vegetables will have a positive 441 
impact on bone on extended-duration missions. Such a diet would also be beneficial for other 442 
biological systems.  443 
  444 
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Table 1. In-flight metabolism-related and dietary intake data for International Space Station crewmembers during 4-d controlled-
intake and monitored-intake sessions1 
 
Characteristic 
or outcome 
variable  
Pre (L-180) Pre (L-45) FD15 FD30 FD60 FD120 FD1802 
  High (n=8) Low (n=9) High (n=8) Low (n=8) High (n = 
8) 
Low (n= 9) Monitored High (n=8) Low 
(n=9) 
High (n = 
9) 
Low (n = 8) High (n=7) Low (n = 7) 
(n = 17) 
Body Mass (kg) 79±12 81±16 82±14 79±12 72±9a 86±14 79±13 79±14 80±13 88±9a 70±11 81±16 84±9 
Female, n (%) 2 (25) 2 (22) 1 (13) 2 (25) 3 (38) 1 (11) 4 (24) 1 (13) 3 (33) 1 (11) 3 (38) 2 (29) 1 (14) 
Cumulative 3-
Week Exercise 
(1000 lb lifted) 
- - - - 327±147b 210±137b 528±302 703±412b 618±273 840±445b 501±174 644±295b 966±557b 
Average CO2 
(mmHg) 
- - - - 3.38±0.44 3.08±0.38 3.13±0.43 3.25±0.41 2.94±0.54 2.69±0.89 2.61±0.58b 2.89±0.47 2.56±0.70 
                            
Energy (kcal/d) 2622±454b 2856±631b 2943±682b 2701±457b 2661±507b 2938±750b 2199±648 2829±691b 2675±594
b 
2992±698b 2435±378b 2399±471a,b 3303±651b 
Energy/Body 
Mass (kcal/d/kg) 
34±7 36±6 36±7 35±7 37±5 35±8 28±7 36±7 34±8 34±9 35±6 31±8 39±6 
Total Protein 
(g) 
116±11 115±26 128±23 111±12 109±16 124±25 98±35 126±25 107±17 130±20 100±14 110±15 131±25 
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Total 
Protein/Body 
Mass (kcal/d/kg) 
1.49±0.21 1.45±0.25 1.58±0.25 1.43±0.22 1.51±0.16 1.47±0.28 1.23±0.39 1.61±0.28 1.35±0.18 1.48±0.24 1.45±0.23 1.38±0.22 1.56±0.24 
Animal Protein 
(g) 
84±8 56±15 95±19 54±8 81±12 61±14 67±29 94±19 52±9 94±17 48±6 81±12 63±13 
Diet Potassium 
(mg) 
2895±300 4723±810 3249±549 4612±535 2835±374 5094±785 3499±1036 3134±642 4469±523 3217±568 4179±394 2810±529 5046±933 
APro:K 29±1 12±2 29±2 12±1 29±1 12±2 18±5 30±3 12±2 29±2 12±2 29±3 13±2 
NEAP 86±11a,b 44±11b 91±14a,b 42±3b 84±10a,b 46±10b 57±14 94±14a,b 46±11 96±13a,b 44±9 88±10a,b 54±9b 
Diet Sulfur 
(mEq/d) 
64±7 b 55±12  71±12a,b 54±6  61±10b 59±12 51±19 70±13a,b 52±8 72±11a,b 48±7b 61±8b 63±11 
Diet Calcium 
(mg) 
1357±192 1369±178 1516±289 1427±203 1172±167 1315±242 1118±397 1252±169 1162±217 1218±240 1135±176 1117±177 1240±198 
Diet Sodium 
(mg) 
4644±1289 4203±642 4525±586 4358±1224 4375±921 4479±805 3726±1145 4631±591 4065±909 4251±995 4399±384 4506±575 3991±943 
Diet Fiber (g) 22±2a,b 42±7b 25±4a 42±6b 21±3a 45±8b 28±7 24±5a,b 40±6b 25±4a,b 38±5b 21±3a 48±8b 
 
1See Statistical Analyses section for full details. Briefly: measures in boldface were included in linear mixed-effects models 
comparing controlled preflight and in-flight sessions to the FD30 monitored session. A separate model using only the in-flight data 
controlled for exercise and CO2, as these were not available before flight. All data are mean ± SD. APro:K, animal protein:potassium 
ratio; FD, flight day; High, high APro:K diet; Low, low APro:K diet; NEAP, net endogenous acid production; Pre (L-X), X days 
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before launch. 2Not all astronauts were measured at FD180 because of flight duration, as described in Methods. aSignificantly different 
from Low for the same FD, bsignificantly different from the monitored session.    
31 
 
Table 2. Bone markers in International Space Station crewmembers before and during flight, by 4-d controlled-intake dietary session1 
Outcome variable Pre (L-180) Pre (L-45) Pre (L-10) FD15 FD30 FD60 FD120
Diet 
 
High Low High Low Uncontrolled High Low Monitored High Low High 
Urine 
NTX  
 
nmol/d 408±207 458±135 376±169 407±166 433±198 766±301 827±251 851±379 803±343 850±243 832±231 7
Δ  -43.7 
±220.4 
40.7 
±95.8 
-55.5 
±70.8 
-45.1 
±171.8 
- 340.9 
±161.1 
386.4 
±197.2 
417.4 
±314.0 
432.7 
±233.2 
360.1 
±231.6 
314.4 
±179.3 
% ∆ 1±32 13±24 -14±18 0±27 - 85±35 111±76 108±74 130±70 91±57 71±45 
Serum 
BSAP 
 
U/L 22±7 26±7 25±7 25±7 28±6 24±6 29±5 28±5 39±5 31±5 38±10 
Δ -4.0±5.1 -2.8±6.4 -3.9 ±6.4 -1.9±4.4 - -0.8±1.7 -0.6±5.2 0.6±4.4 8.2±7.0 6.4±3.7 10.0 ±8.7 1
% Δ -15±19 -9±23 -13±22 -8±17 - -3±7 -1±15 3±14 29±27 28±16 37±30 
Urine 
calcium 
mmol/d 5±2 3±2 5±2 4±1 5±3 8±4 7±2 9±3 9±2 6±3 8±2 
Δ 0.0±2.8 -2.1±2.5 -1.2 ±2.2 -1.2±2.0 - 3.7±2.5 1.9±3.4 3.5±2.8 3.4±3.3 0.8±2.4 1.3±2.6 
% Δ 24±83 -32±25 -12±24 -13±52 - 83±40 77±100 97±88 99±112 29±50 39±60 
 
 
1Data are expressed as actual amount or concentration, as change (Δ) from the Pre (L-10) session when crewmembers were not on a 
controlled diet, and as percentage change (% Δ) from the Pre (L-10) session. Data are mean ± SD. APro:K, animal protein:potassium 
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ratio; BSAP, bone-specific alkaline phosphatase; FD, flight day; High, high APro:K diet; Low, low APro:K diet; NTX, N-telopeptide; 
Pre (L-X), X days before launch. 
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Table 3. Results of 2 linear mixed-effects models investigating the relationship of changes in urinary NTX excretion before and during 
spaceflight to HPK and LPK diets (preflight and in-flight model), or the relationship of changes in urinary NTX (relative to the 
monitored diet) only during flight to HPK and LPK diets (in-flight model).1  
 
1Changes and percentage changes in urinary NTX excretion (Table 2) were between each 4-d controlled-diet session and the Pre (L-
10) session when crewmembers were not on a controlled diet. The preflight and in-flight model controlled for body weight; sex; age; 
energy; NEAP; dietary sulfur, sodium, and fiber; flight day; and in-flight status. The in-flight model controlled for CO2 and 
cumulative resistive exercise for 3 wk before data collection. Note: the data include all subjects, but 1 subject (outlier) was removed 
from these analyses because of an extremely high response during the FD30 session relative to the preflight baseline (as discussed in 
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Results, and shown in Supplemental Figure 1). APro:K, animal protein:potassium ratio; HPK, high APro:K; LPK, low APro:K; 
NEAP, net endogenous acid production; NTX, N-telopeptide. 
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Table 4. Results of 2 linear mixed-effects models investigating the relationship of changes in serum BSAP before and during 
spaceflight to HPK and LPK diets (preflight and in-flight model), or the relationship of changes in BSAP (relative to the monitored 
diet) only during flight to HPK and LPK diets (in-flight model).1   
 
1Changes and percentage changes in BSAP concentration (Table 2) were between each 4-d controlled-diet session and the Pre (L-10) 
session when crewmembers were not on a controlled diet. The preflight and in-flight model controlled for body weight; sex; age; 
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energy; NEAP; dietary sulfur, sodium, and fiber; flight day, and in-flight status. The in-flight model controlled for CO2 and 
cumulative resistive exercise for 3 wk before data collection. APro:K, animal protein:potassium ratio; BSAP, bone-specific alkaline 
phosphatase; HPK, high APro:K; LPK, low APro:K; NEAP, net endogenous acid production.   
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Table 5. Results of 2 linear mixed-effects models investigating the relationship of changes in urinary calcium before and during 
spaceflight to HPK and LPK diets (preflight and in-flight model), or the relationship of changes in urinary calcium (relative to the 
monitored diet) only during flight to HPK and LPK diets (in-flight model).1   
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1Changes and percentage changes in urinary calcium concentration (Table 2) were between each 4-d controlled-diet session and the 
Pre (L-10) session when crewmembers were not on a controlled diet. The preflight and in-flight model controlled for body weight; 
sex; age; energy; NEAP; dietary sulfur, sodium, and fiber; flight day, and in-flight status. The in-flight model controlled for average 
CO2 and cumulative resistive exercise for 3 wk before data collection. APro:K, animal protein:potassium ratio; BSAP, bone-specific 
alkaline phosphatase; HPK, high APro:K; LPK, low APro:K; NEAP, net endogenous acid production.
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Legends for figures 
FIGURE 1. Box plots of urinary NTX and calcium, and serum BSAP of crewmembers 
consuming a 4-d diet with controlled HPK or LPK intake, or an intake that was not controlled 
but monitored, on the indicated days before and during spaceflight. Black lines indicate median 
values for each group. Boxes represent interquartile range (IQR). Small circles indicate 
observations outside 1.5*IQR. Box shading: no shading, HPK diet; light shading, LPK diet; 
heavy shading, monitored diet. APro:K, animal protein:potassium ratio; BSAP, bone-specific 
alkaline phosphatase; FD, flight day; HPK, high APro:K diet; LPK, low APro:K diet; L-X, the 
Xth day before launch; NTX, N-telopeptide. 
 
FIGURE 2. Dietary NEAP estimated from crewmembers’ diet for 4 d collected around FD30, 
used as a proxy for their typical intake throughout their mission, was related to the change in 
lumbar spine BMC after flight (P < 0.01). Each point represents a single crewmember. The 
association remained significant after adjusting for age and sex (P < 0.05). BMC, bone mineral 
content; L, lumbar; NEAP, net endogenous acid production.  
 
FIGURE 3. Relationship of NTX to dietary APro:K before (Pre) and during bed rest in 
sedentary (Control, n = 6) and exercising subjects (n = 5). 
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Figure 1. Box plots of urinary NTX and calcium, and serum BSAP of crewmembers consuming 
a 4-d diet with controlled HPK or LPK intake, or an intake that was not controlled but 
monitored, on the indicated days before and during spaceflight. Black lines indicate median 
values for each group. Boxes represent interquartile range (IQR). Small circles indicate 
observations outside 1.5*IQR. Box shading: no shading, HPK diet; light shading, LPK diet; 
heavy shading, monitored diet. APro:K, animal protein:potassium ratio; BSAP, bone-specific 
alkaline phosphatase; FD, flight day; HPK, high APro:K diet; LPK, low APro:K diet; L-X, the 
Xth day before launch; NTX, N-telopeptide. 
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Figure 2. Dietary NEAP estimated from crewmembers’ diet for 4 d collected around FD30, used 
as a proxy for their typical intake throughout their mission, is related to the change in lumbar 
spine BMC after flight (P < 0.01). Each point represents a single crewmember. The association 
remained significant after adjusting for age and sex (P < 0.05). BMC, bone mineral content; L, 
lumbar; NEAP, net endogenous acid production.  
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Figure 3. Dietary APro:K before and during bed rest in sedentary (n=6) and exercising subjects 
(n=5). 
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Supplemental Table 1. Dietary intake before and during spaceflight1 
  Pre (L‐180)  Pre (L‐45) FD15 FD30 FD60 FD120 FD180* 
Dietary intake  High (n=8)  Low (n=9)  High (n=8)  Low (n=8)  High (n = 8)  Low (n= 9) 
Monitored 
High (n=8)  Low (n=9)  High (n = 9)  Low (n = 8)  High (n=7)  Low (n = 7) 
(n = 17)
Total Protein (g)  116±11  115±26  128±23 111±12 109±16 124±25 98±35 126±25 107±17 130±20 100±14 110±15 131±25 
Animal Protein (g)  84±8  56±15  95±19 54±8 81±12 61±14 67±29 94±19 52±9 94±17 48±6 81±12 63±13 
Vegetable Protein (g)  31±5  59±14  32±7  56±9 27±6 63±16 31±9 32±8 54±11 34±7 51±12 28±7 68±17 
Diet Calcium (mg)  1357±192  1369±178  1516±289 1427±203 1172±167 1315±242 1118±397  1252±169 1162±217 1218±240 1135±176 1117±177 1240±198 
Diet Sodium (mg)  4644±1289  4203±642  4525±586 4358±1224 4375±921 4479±805 3726±1145  4631±591 4065±909 4251±995 4399±384 4506±575 3991±943 
Cholesterol (mg)  412±126  212±64  434±108 231±64 394±137 216±56 302±150 448±104 234±82 403±107 219±71 439±99 220±57 
Total Saturated Fatty Acids 
(SFA) (g) 
31±8  21±5  33±7  23±8  31±7  23±9  25±10  31±8  24±9  34±8  21±6  28±9  26±6 
Total Monounsaturated 
Fatty Acids (MUFA)(g) 
35±10  51±19  36±9  50±14  33±10  59±23  29±9  37±12  46±12  37±10  42±12  31±9  63±21 
Total Polyunsaturated Fatty 
Acids (PUFA) (g) 
18±5  27±7  19±3  25±7  18±4  28±11  16±5  19±6  25±7  19±4  23±8  16±5  33±11 
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Total Dietary Fiber (g)  22±2  42±7  25±4  42±6 21±3 45±8 28±7 24±5 40±6 25±4 38±5 21±3 48±8 
Total Fat (g)  90±21  106±31  94±17 104±23 89±20 116±41 76±26 92±25 101±22 97±19 91±25 80±20 128±37 
Total Carbohydrate (g)  341±82  362±82  397±123 334±76 357±86 353±93 288±84 374±109 336±100 403±131 306±51 310±88 409±79 
Total Vitamin A Activity 
(International Units) (IU) 
6320±2026  12647±6314  8246±4496  14364±3698  9210±3690  15896±5946  9835±4179  6824±2111  12196±3698  6909±4534  12916±4503  5615±2683  12543±5942 
Vitamin D (mcg)  4±1  3±1  5±1  3±1 6±4 10±14 14±13 8±6 3±2 6±5 5±7 8±7 5±3 
Total Alpha‐Tocopherol 
Equivalents (mg) 
15±4  30±9  18±5  25±9  14±4  36±19  22±10  18±6  27±9  21±9  24±9  14±4  38±10 
Vitamin K (mcg)  81±32  142±42  99±36 166±29 82±35 174±32 126±56 85±24 142±33 78±28 153±31 99±35 141±27 
Vitamin C (mg)  78±38  159±70  102±94 162±50 61±18 183±58 134±52 119±86 146±45 93±91 131±57 67±27 184±54 
Thiamin (mg)  2.13±0.45  2.31±0.60  2.31±0.57 2.24±0.52 2.03±0.54 2.73±0.77 1.87±0.60  2.27±0.59 2.09±0.41 2.56±0.58 2.00±0.23 2.01±0.27 2.70±0.67 
Riboflavin (mg)  2.42±0.42  2.23±0.32  2.56±0.48 2.19±0.33 2.22±0.45 2.52±0.61 2.16±0.69  2.62±0.57 2.14±0.33 2.66±0.65 2.05±0.32 2.28±0.25 2.58±0.37 
Niacin (mg)  27.08±4.20  28.44±8.45  29.77±9.25 28.43±3.95 25.39±7.17 34.28±8.02 25.64±9.30  31.53±8.20 25.74±4.43 32.73±7.04 25.26±5.36 23.53±5.21 34.81±7.45 
Pantothenic acid (mg)  5.45±0.68  5.41±0.74  5.97±0.50 5.62±1.08 5.17±0.61 7.34±3.14 6.63±2.93  5.73±0.83 5.17±0.87 6.41±1.59 5.21±0.51 5.39±0.68 6.03±1.17 
Vitamin B‐6 (mg)  1.97±0.31  2.25±0.59  2.30±0.69 2.24±0.30 1.82±0.47 2.90±1.02 2.35±0.95  2.40±0.58 2.09±0.36 2.47±0.67 1.96±0.21 1.76±0.28 2.75±0.48 
Folate (mcg)  354±87  592±115  391±79 549±72 340±91 672±188 441±165 392±88 523±71 399±150 526±78 333±37 662±143 
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Vitamin B‐12 (mcg)  5.38±0.91  4.69±1.59  6.11±1.07 4.07±1.11 5.53±0.96 8.18±8.04 7.15±5.92  6.28±1.09 3.98±0.92 7.06±4.31 4.06±1.07 4.87±0.97 6.62±2.36 
Choline (mg)  437±65  398±75  492±79 384±63 412±71 419±93 366±136 486±76 372±67 479±81 354±50 448±68 436±81 
Phosphorus (mg)  1955±290  2017±353  2169±291 2004±244 1876±279 2136±372 1639±506  2099±386 1940±302 2096±357 1836±277 1877±239 2222±375 
Magnesium (mg)  419±54  674±145  427±64 662±91 342±48 701±134 392±111 397±73 589±99 415±63 544±92 353±66 716±149 
Iron (mg)  17±2  22±4  20±5  23±5 15±3 24±4 17±5 20±4 21±4 19±4 21±3 16±3 26±6 
Zinc (mg)  15±3  15±3  16±3  14±2 13±2 18±5 14±4 16±4 13±2 17±3 13±1 15±2 17±3 
Copper (mg)  2.04±0.45  2.98±0.49  2.19±0.41 3.14±0.62 1.76±0.28 3.52±0.62 2.05±0.50  2.13±0.45 2.77±0.47 2.22±0.46 2.71±0.36 1.82±0.19 3.37±0.58 
Selenium (mcg)  176±31  134±32  196±41 135±28 181±34 142±32 137±49 195±46 127±29 198±39 121±22 163±18 155±32 
Sodium (mg)  4644±1289  4203±642  4525±586 4358±1224 4375±921 4479±805 3726±1145  4631±591 4065±909 4251±995 4399±384 4506±575 3991±943 
Potassium (mg)  2895±300  4723±810  3249±549 4612±535 2835±374 5094±785 3499±1036  3134±642 4469±523 3217±568 4179±394 2810±529 5046±933 
Manganese (mg)  4.63±0.48  8.15±2.49  5.00±1.34 7.99±1.31 4.16±0.91 9.04±2.41 5.17±1.67  5.05±1.30 7.33±1.77 5.26±1.10 6.74±1.14 4.45±0.64 9.68±1.98 
PUFA 18:2 (linoleic acid) (g)  16±5  25±7  17±3  23±7 16±4 26±10 14±5 17±5 23±7 17±4 21±8 14±4 30±10 
PUFA 18:3 (linolenic acid) 
(g) 
1.41±0.44  1.70±0.38  1.45±0.19  1.61±0.50  1.57±0.34  1.62±0.63  1.23±0.43  1.44±0.39  1.62±0.34  1.44±0.33  1.55±0.63  1.21±0.28  2.10±0.51 
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PUFA 20:5 
(eicosapentaenoic acid 
[EPA]) (g) 
0.09±0.09  0.07±0.04  0.06±0.05  0.11±0.10  0.10±0.06  0.09±0.10  0.08±0.07  0.06±0.05  0.07±0.05  0.06±0.06  0.09±0.06  0.07±0.05  0.06±0.05 
PUFA 22:6 
(docosahexaenoic acid 
[DHA]) (g) 
0.13±0.09  0.11±0.03  0.12±0.04  0.15±0.15  0.16±0.06  0.14±0.13  0.14±0.14  0.12±0.08  0.09±0.05  0.11±0.06  0.14±0.11  0.09±0.05  0.12±0.06 
Methionine (g)  2.76±0.29  2.26±0.54  3.09±0.60 2.22±0.27 2.65±0.43 2.42±0.51 2.21±0.88  3.04±0.61 2.10±0.34 3.11±0.53 1.97±0.27 2.63±0.35 2.57±0.47 
Cystine (g)  1.61±0.20  1.51±0.32  1.78±0.27 1.44±0.15 1.53±0.26 1.58±0.34 1.31±0.45  1.75±0.33 1.41±0.23 1.80±0.26 1.32±0.22 1.56±0.20 1.70±0.32 
Caffeine (mg)  84±68  102±64  83±61 99±90 67±52 114±79 120±126 67±40 127±90 131±88 89±78 174±171 72±54 
Phytic Acid (mg)  949±244  2202±637  987±348 2038±519 764±208 2317±833 955±357 985±372 2025±509 1090±337 1799±610 883±325 2637±802 
Oxalic Acid (mg)  226±54  538±136  231±61 559±105 201±57 623±102 255±104 237±69 521±146 246±61 483±115 216±59 602±137 
Water (g)  4031±1209  4267±887  4467±1471 4659±1119 3159±757 2889±663 2654±675  2904±865 3377±727 3230±1045 3037±477 3114±424 3622±1015 
Beta‐Carotene (mcg)  2432±1054  6048±3289  3451±2773 6741±1877 4157±2322 7414±3017 4229±2045  2434±1075 5770±1992 2724±2735 6042±2369 2261±1303 5947±3086 
Lutein + Zeaxanthin (mcg)  1414±488  3013±852  1621±569 3138±822 1549±568 3731±575 2325±1310  1519±321 2824±1032 1333±322 2795±398 1541±620 2888±962 
Lycopene (mcg)  2151±2679  5357±1708  1402±1188 8148±2698 2451±2424 7415±2380 4300±2809  1761±2602 6733±3303 1125±1022 5726±1435 1556±1539 6121±2683 
Omega‐3 Fatty Acids (g)  1.67±0.60  1.89±0.38  1.66±0.22 1.90±0.60 1.88±0.42 1.96±0.74 1.45±0.64  1.67±0.52 1.79±0.33 1.65±0.41 1.81±0.63 1.39±0.34 2.21±0.61 
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Soy Isoflavones 
(daidzein+genistein+glycitei
n mg) 
4.06±3.90  15.83±6.37  3.52±3.02  21.59±11.01  2.55±1.57  22.65±7.29  5.71±5.53  4.21±3.61  15.16±7.63  3.38±3.42  19.35±7.38  4.82±4.54  16.21±6.53 
Flavonoids (Coumestrol, 
Biochanin A, Formononetin, 
mg) 
0.00±0.00  0.57±0.63  0.31±0.56  0.59±0.63  0.16±0.43  0.45±0.53  0.48±0.72  0.16±0.43  0.39±0.57  0.14±0.40  1.06±0.58  0.01±0.01  0.35±0.48 
Added Sugars (g)  143±55  132±43  172±68 100±38 155±50 113±47 105±46 158±61 114±53 175±77 101±35 129±63 145±37 
1Data are mean ± SD. APro:K, animal protein:potassium ratio; FD, flight day; High, high APro:K diet; Low, low APro:K diet; Pre (L-
X), X days before launch; PUFA, polyunsaturated fatty acids. *Not all astronauts were measured at FD180 because of flight duration
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Supplemental Table 2. Dietary intake data before (Pre-Bed Rest) and after (Bed Rest) the 70-d bed rest study1  
  
1The data are 7-d averages ± SD before bed rest and 7-d averages ± SD during the last week of bed rest. APro:K, animal 
protein:potassium ratio.  
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Supplemental Figure 1. Change in urinary NTX of individual astronauts from the preflight baseline1  
 
1The flight dates shown are approximate, for de-identification of the subjects.  NTX, N-telopeptide. 
 
